Ali Nael Selected Research

Neoplasms (Cancer)

9/2022	UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression.
1/2021	A Liver Transplant for Local Control in a Pediatric Patient with Metastatic TFE3-Associated Perivascular Epithelioid Cell Tumor (PEComa) to the Liver.
5/2013	De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.
3/2013	PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali Nael Research Topics

Disease

4	Neoplasms (Cancer) 09/2022 - 03/2013
2	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 05/2013 - 03/2013
1	Anemia 02/2022
1	Abdominal Pain (Pain, Abdominal) 02/2022
1	Choroid Plexus Papilloma 01/2022
1	Cytopenia 01/2021
1	Perivascular Epithelioid Cell Neoplasms 01/2021
1	Plasma Cell Neoplasms 06/2019
1	HIV Infections (HIV Infection) 06/2019
1	Philadelphia Chromosome 01/2019
1	Atrophy 01/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Systemic Mastocytosis 01/2019
1	Pneumoperitoneum 07/2016
1	Brain Neoplasms (Brain Tumor) 05/2013
1	Leukemia 03/2013

Drug/Important Bio-Agent (IBA)

2	Tyrosine Kinase InhibitorsIBA 01/2019 - 05/2013
1	UbiquitinIBA 09/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	CopperIBA 01/2021
1	midostaurinIBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	Alcian BlueIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2013
1	Arsenic Trioxide (Trisenox)FDA Link 03/2013
1	TOR Serine-Threonine KinasesIBA 03/2013
1	Phosphotransferases (Kinase)IBA 03/2013

Therapy/Procedure

2	Therapeutics 05/2013 - 03/2013
1	Liver Transplantation 01/2021
1	Organ Transplantation 06/2019
1	Laparotomy 07/2016